日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Japan OKs stem cells for corneal disease

By Wang Xu in Tokyo | China Daily | Updated: 2019-03-07 09:38
Share
Share - WeChat
Hideyuki Okano (L), a Japanese physiology professor and the current dean of Keio University School of Medicine and Masaya Nakamura, a Japanese orthopedics professor, attend a press conference to mention about iPS clinical research in Tokyo on Feb 18, 2019. [Photo/IC]

Japan's Health Ministry on Tuesday granted permission for world's first clinical test with artificially derived stem cells for the treatment of a corneal disease that causes decreasing vision, local media reported.

The corneal test, the sixth case authorized by the Japanese government using induced pluripotent stem (iPS) cells, will be conducted by a team of researchers from Osaka University led by Professor Kohji Nishida.

With artificial cultivation, the iPS cells can grow into any type of body tissues.

According to Nishida, the team will transplant a 0.05-mm-thick sheet-like corneal tissue produced from iPS cells into the eyes of four patients, all of whom suffer from diseases that bring corneal haze or decreased vision.

The first transplant operation could be carried out as early as June, Nishida said, adding the treatment might come into common use within five to six years.

The researchers will keep an eye on the safety and the effectiveness of the operation for one year after the surgery and are required to submit reports to the Health Ministry after the studies on two of the patients are completed.

The Osaka University team's research would be a breakthrough for patients with corneal disease as there are not enough corneas for transplants due to limited number of donors, officials from the Health Ministry said. They cited data that a total of 1,600 patients are currently waiting for corneal donations in Japan.

"I will promote clinical research as safely and promptly as possible and develop it for standard medical care," Nishida told reporters after the panel discussion.

Developed by a team led by Kyoto University's Shinya Yamanaka, the iPS cells can theoretically grow into any type of body tissue.

Other cases using iPS cells already approved by the Japanese government include treatments for platelet transfusion, Parkinson's disease, heart disease and damaged spinal cords

In recognition for his discovery that "mature cells can be reprogrammed to become pluripotent", Yamanaka was awarded the Nobel Prize in Physiology and Medicine in 2012.

In 2014, backed by the government, Japan's Riken institute conducted the world's first clinical test using iPS cells by transplanting artificial retina cells into an individual with a another type of eye disease.

Kyodo News contributed to this story.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 波多野结衣一级 | 欧美天堂在线观看 | 新中文字幕 | 在线免费观看黄网站 | 亚洲欧美日本在线 | 国产一区二区影院 | av在线成人| 亚洲成人一区二区 | 国产视频一 | zzjj国产 | 黄色片网站视频 | 国产女片a归国片aa 精品国产一二三区 | 成人免费视频视频 | 国产精品xxxxx | 久久美女免费视频 | 亚洲啊v | 国产69精品久久久久久 | 日韩字幕在线观看 | 天天做天天爽 | 日韩欧美国产一区二区三区 | 91在线无精精品一区二区 | 久久青青操 | 黄色a级片在线观看 | 免费在线a| 日本一区二区在线播放 | 久久精品国产成人av | 日本精品成人 | 国产精品久久免费视频 | 欧美一级片在线看 | 视频一区二区中文字幕 | h片在线播放 | 日韩精品视频中文字幕 | 亚洲插插 | 国产日产在线观看 | 久久网站免费 | 日本黄色视 | 欧美精品999 | 麻豆精品在线视频 | 久久精品一区二区 | 西西特级444大胆高清张悠雨 | 黄色一级大片 |